PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28267564-1	2017	17beta-Hydroxysteroid dehydrogenase type 3 (17beta-HSD3) is expressed almost exclusively in the testes and specifically converts the weak androgenic androstenedione to active testosterone (T) in the presence of NADPH.	Testosterone	175-187	2,4-dienoyl-CoA reductase 1	Homo sapiens	211-216	
16079965-10	2005	Generation of redox potential through synthesis of the enzyme cofactor NADPH, a byproduct of glucocorticoid metabolism by 11 betaHSD-1, may potentiate testosterone biosynthesis, as NADPH is the cofactor used by steroidogenic enzymes such as type 3 17beta-hydroxysteroid dehydrogenase.	Testosterone	151-163	2,4-dienoyl-CoA reductase 1	Homo sapiens	71-76	
16079965-10	2005	Generation of redox potential through synthesis of the enzyme cofactor NADPH, a byproduct of glucocorticoid metabolism by 11 betaHSD-1, may potentiate testosterone biosynthesis, as NADPH is the cofactor used by steroidogenic enzymes such as type 3 17beta-hydroxysteroid dehydrogenase.	Testosterone	151-163	2,4-dienoyl-CoA reductase 1	Homo sapiens	181-186	
10898110-1	2000	Human prostatic steroid 5alpha-reductase, encoded by the SRD5A2 gene on chromosome band 2p23, catalyses the irreversible conversion of testosterone to dihydrotestosterone (DHT), the most active androgen in the prostate, with NADPH as its cofactor.	Testosterone	135-147	2,4-dienoyl-CoA reductase 1	Homo sapiens	225-230